Lv3
306 积分 2023-03-22 加入
Evaluating Clinical Safety and Analytical Impact of Subvisible Silicone Oil Particles in Biopharmaceutical Products
26天前
已完结
以药品作用为主的药械组合产品注册法规体系的思考和建议
28天前
已完结
Challenging the Norm: A Multidisciplinary Perspective on Intravenous to Subcutaneous Bridging Strategies for Biologics
1个月前
已完结
Current views on N-glycolylneuraminic acid in therapeutic recombinant proteins
6个月前
已完结
A Predictive Modeling Approach to Support the Overfill Volume Definition of Liquid-in-Vial Drug Products
8个月前
已完结
Syringe Filling of High-Concentration mAb Products Using Peristaltic Pump-Based Mechanism: Challenges and Mitigation Strategies
11个月前
已完结
Experience with host cell protein impurities in biopharmaceuticals
11个月前
已完结
A Review of Recent FDA-Approved Biologic-Device Combination Products
1年前
已完结
Assessing detergent‐mediated virus inactivation, protein stability, and impurity clearance in biologics downstream processes
1年前
已完结
皖公网安备34019202002308
